SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharma gets USFDA’s nod for Oxymorphone Hydrochloride

30 Apr 2015 Evaluate

Sun Pharmaceutical Industries has received US Food and Drugs Administration’s (USFDA) approval for a painkiller tablet called ‘Oxymorphone Hydrochloride’. Including this medicine, the company has received total seven approvals from US FDA in last one year, these medicine are- Oxymorphone Hydrochloride, Fesoterodine Fumarate, Opcicon One-step, Clonazepam, Clonidine Hydrochloride, Hydrochlorothiazide and Furosemide.

Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.

Sun Pharma Inds. Share Price

1672.30 -2.90 (-0.17%)
20-Apr-2026 12:28 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1672.30
Dr. Reddys Lab 1238.60
Cipla 1238.25
Zydus Lifesciences 940.00
Lupin 2329.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×